Work experience

• Director of Biosimilars, Emerging Therapies

  Cardinal Health

  2023.07-Current

  (2 years)

  (2 years 4 months) 2 years 2 months
• Market Access & Account Management, Contracting and Pricing

  Organon

  2021.11-2023.07

  (2 years)

  (1 year 9 months) In this role, I am responsible for leading contracting strategy efforts across numerous books of business, including GPOs, Payers, 340B, Federal, and Device. I also manage quarterly business reviews for contracted customers and conduct quarterly forecasting and profitability statements. I monitor and effectively react to local market conditions for changes impacting business and foster ongoing trust and relationships with internal stakeholders and customers. Finally, I navigate various operational complexities within the organization to ensure success. My accomplishments include: • I created and streamlined data analysis and deal-modeling techniques for enhanced contracting opportunities. • I led a culture team for Organon for Contracting and Market Access department to establish a culture for our new company. • I was hand selected from the Merck team to build out the new company as Founding Member from the ground up and manage the contracting strategy.
• Associate Director

  US Oncology Biosimilar Marketing

  2021.06-2021.11

  (6 months)

  In this role, I drove strategic thinking on multi-brand, multi-national accounts and served as a trusted voice to partner and guide clients, creatives, and account management teams. I harnessed insights to develop integrated marketing briefs and inspire breakthroughs. I also allocated an annual budget and led a resource team to optimize sales team performance. Finally, I designed segmented objectives within the US market through collaboration with management and cross-functional team leaders. My accomplishments included: • I directed the launch brand strategy for a new Oncology Biosimilar entrant into the marketplace and market research team for insight into strategy development. • I spearheaded the NDC transition workstream from Merck to Organon. • I created a digital promotion plan during COVID economic downturn to pivot, resulting in strong sales growth.
• Associate Director US Oncology Biosimilar Marketing Strategy

  Merck

  2020.06-2021.06

  (a year)

  3 years 11 months (1 year 1 month)
• Acute Care Institutional Executive

  Wisconsin

  2017.08-2020.05

  (3 years)

  (2 years 10 months) Managed 2 large academic medical centers and utilized field emails, e- resources and online customer meetings to digitalize interactions. Launched, educated, and sold Prevymis, Dificid, Noxafil, and Zinplava products to clients. Led collaboration efforts with Integrated Account Management team, Antibiotic, Biosimilars, Virology, and Oncology counterparts. • Significantly exceeded sales goals of Noxafil by 127% and Prevymis saw 177% growth-top in country. • Championed Dificid formulary win and contracting completion with all 7 SSM hospitals and Prevymis formulary win at UW Hematology-Oncology/Infectious disease.

Educational experience

• Loyola University Chicago

  MS

  2003.01-2006.01

  (3 years)

Certificates